Redirect Notice
 The previous page is sending you to https://www.globenewswire.com/news-release/2020/05/05/2027469/0/en/Diffusion-Pharmaceuticals-Announces-FDA-Accelerated-Review-of-TSC-Clinical-Development-Plan-to-Treat-COVID-19-Patients-with-ARDS.html.

 If you do not want to visit that page, you can return to the previous page.